GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Goodness Growth Holdings Inc (OTCPK:GDNSF) » Definitions » Beneish M-Score

Goodness Growth Holdings (Goodness Growth Holdings) Beneish M-Score : -0.79 (As of May. 16, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Goodness Growth Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.79 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Goodness Growth Holdings's Beneish M-Score or its related term are showing as below:

GDNSF' s Beneish M-Score Range Over the Past 10 Years
Min: -50.05   Med: -2.32   Max: 8.2
Current: -0.79

During the past 13 years, the highest Beneish M-Score of Goodness Growth Holdings was 8.20. The lowest was -50.05. And the median was -2.32.


Goodness Growth Holdings Beneish M-Score Historical Data

The historical data trend for Goodness Growth Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goodness Growth Holdings Beneish M-Score Chart

Goodness Growth Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.75 0.22 -2.99 -0.95

Goodness Growth Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.48 -3.64 -3.04 -0.95 -0.79

Competitive Comparison of Goodness Growth Holdings's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Goodness Growth Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goodness Growth Holdings's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Goodness Growth Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Goodness Growth Holdings's Beneish M-Score falls into.



Goodness Growth Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Goodness Growth Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.6599+0.528 * 0.9665+0.404 * 0.5173+0.892 * 1.1929+0.115 * 1.3916
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7282+4.679 * -0.154659-0.327 * 1.103
=-0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $18.61 Mil.
Revenue was 24.087 + 24.173 + 24.675 + 20.197 = $93.13 Mil.
Gross Profit was 12.244 + 12.055 + 13.197 + 9.331 = $46.83 Mil.
Total Current Assets was $147.18 Mil.
Total Assets was $190.88 Mil.
Property, Plant and Equipment(Net PPE) was $34.66 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.39 Mil.
Selling, General, & Admin. Expense(SGA) was $30.78 Mil.
Total Current Liabilities was $184.24 Mil.
Long-Term Debt & Capital Lease Obligation was $29.05 Mil.
Net Income was -6.711 + -4.583 + -5.229 + -7.329 = $-23.85 Mil.
Non Operating Income was 1.197 + -0.511 + 0.295 + 3.05 = $4.03 Mil.
Cash Flow from Operations was -1.19 + -0.46 + 1.655 + 1.634 = $1.64 Mil.
Total Receivables was $4.26 Mil.
Revenue was 19.088 + 19.043 + 18.854 + 21.09 = $78.08 Mil.
Gross Profit was 9.52 + 8.516 + 9.537 + 10.367 = $37.94 Mil.
Total Current Assets was $115.56 Mil.
Total Assets was $158.63 Mil.
Property, Plant and Equipment(Net PPE) was $28.54 Mil.
Depreciation, Depletion and Amortization(DDA) was $4.04 Mil.
Selling, General, & Admin. Expense(SGA) was $35.43 Mil.
Total Current Liabilities was $95.17 Mil.
Long-Term Debt & Capital Lease Obligation was $65.53 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(18.607 / 93.132) / (4.262 / 78.075)
=0.199792 / 0.054589
=3.6599

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(37.94 / 78.075) / (46.827 / 93.132)
=0.485943 / 0.502802
=0.9665

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (147.177 + 34.66) / 190.884) / (1 - (115.557 + 28.541) / 158.633)
=0.047395 / 0.091627
=0.5173

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=93.132 / 78.075
=1.1929

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.037 / (4.037 + 28.541)) / (3.388 / (3.388 + 34.66))
=0.123918 / 0.089045
=1.3916

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(30.775 / 93.132) / (35.429 / 78.075)
=0.330445 / 0.453782
=0.7282

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((29.045 + 184.238) / 190.884) / ((65.526 + 95.174) / 158.633)
=1.117344 / 1.01303
=1.103

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-23.852 - 4.031 - 1.639) / 190.884
=-0.154659

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Goodness Growth Holdings has a M-score of -0.74 signals that the company is likely to be a manipulator.


Goodness Growth Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Goodness Growth Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Goodness Growth Holdings (Goodness Growth Holdings) Business Description

Traded in Other Exchanges
Address
885 West Georgia Street, Suite 2200 HSBC Building, Vancouver, BC, CAN, V6C 3E8
Goodness Growth Holdings Inc is a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. It operates in one business segment, namely the Cannabis segment that cultivates, processes, and distributes medical and adult-use cannabis products in a variety of formats, as well as related accessories in Maryland, Minnesota, New Mexico, New York, and formerly Arizona, and Ohio.
Executives
Chicago Atlantic Manager, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Gp Holdings, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group, Lp 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Group Gp, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Chicago Atlantic Advisers, Llc 10 percent owner 420 NORTH WABASH AVENUE, SUITE 500, CHICAGO IL 60611
Chicago Atlantic Credit Opportunities, Llc 10 percent owner 420 N WABASH AVE STE 500, CHICAGO IL 60611
Joshua Rosen director 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Victor E. Mancebo director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Christian Gonzales Ocasio officer: Chief Operating Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Amber Holly Shimpa director, officer: Chief Administrative Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Patrick Peters officer: EVP of Retail C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
J Michael Schroeder officer: General Counsel & CCO 3680 VICTORA STREET N, SHOREVIEW MN 55126
John Andrew Heller officer: Chief Financial Officer C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Ross Michael Hussey director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402
Judd Theodore Nordquist director C/O VIREO HEALTH INTERNATIONAL, INC., 207 SOUTH 9TH STREET, MINNEAPOLIS MN 55402